|
1
|
Cai JR, Chen Z, Chen XL, Huang H, Lin X
and Miao B: Coexpression network analysis identifies a novel
nine-RNA signature to improve prognostic prediction for prostate
cancer patients. Biomed Res Int. 2020:42642912020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wild CP, Espina C, Bauld L, Bonanni B,
Brenner H, Brown K, Dillner J, Forman D, Kampman E, Nilbert M, et
al: Cancer prevention Europe. Mol Oncol. 13:528–534. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang Y, Chen R, Sun T, Zhao L, Liu F, Ren
S, Wang H, Lu X, Gao X, Xu C and Sun Y: Efficacy and safety of
combined androgen blockade with antiandrogen for advanced prostate
cancer. Curr Oncol. 26:e39–e47. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Corona G, Baldi E and Maggi M: Androgen
regulation of prostate cancer: Where are we now? J Endocrinol
Invest. 34:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Damber JE and Aus G: Prostate cancer.
Lancet. 371:1710–1721. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Steele CB, Li J, Huang B and Weir HK:
Prostate cancer survival in the United States by race and stage
(2001–2009): Findings from the CONCORD-2 study. Cancer. 123 (Suppl
24):S5160–S5177. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moyer VA; U.S. Preventive services task
force, : Screening for prostate cancer: U.S. Preventive services
task force recommendation statement. Ann Intern Med. 157:120–134.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Loeb S, Bjurlin MA, Nicholson J, Tammela
TL, Penson DF, Carter HB, Carroll P and Etzioni R: Overdiagnosis
and overtreatment of prostate cancer. Eur Urol. 65:1046–1055. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Welch HG and Albertsen PC: Reconsidering
prostate cancer mortality-the future of PSA screening. N Engl J
Med. 382:1557–1563. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mizoguchi T, Ikeda S, Watanabe S, Sugawara
M and Itoh M: Mib1 contributes to persistent directional cell
migration by regulating the Ctnnd1-Rac1 pathway. Proc Natl Acad Sci
USA. 114:E9280–E9289. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Berndt JD, Aoyagi A, Yang P, Anastas JN,
Tang L and Moon RT: Mindbomb 1, an E3 ubiquitin ligase, forms a
complex with RYK to activate Wnt/β-catenin signaling. J Cell Biol.
194:737–750. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin Y, Blue EK, Dixon S, Shao Z and
Gallagher PJ: A death-associated protein kinase (DAPK)-interacting
protein, DIP-1, is an E3 ubiquitin ligase that promotes tumor
necrosis factor-induced apoptosis and regulates the cellular levels
of DAPK. J Biol Chem. 277:46980–46986. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang L and Gallagher PJ: Mind bomb 1
regulation of cFLIP interactions. Am J Physiol Cell Physiol.
297:C1275–C1283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Itoh M, Kim CH, Palardy G, Oda T, Jiang
YJ, Maust D, Yeo SY, Lorick K, Wright GJ, Ariza-McNaughton L, et
al: Mind bomb is a ubiquitin ligase that is essential for efficient
activation of Notch signaling by delta. Dev Cell. 4:67–82. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ray J, Hoey C, Huang X, Jeon J, Taeb S,
Downes MR, Boutros PC and Liu SK: MicroRNA-198 suppresses prostate
tumorigenesis by targeting MIB1. Oncol Rep. 42:1047–1056.
2019.PubMed/NCBI
|
|
16
|
Hu YM, Lou XL, Liu BZ, Sun L, Wan S, Wu L,
Zhao X, Zhou Q, Sun MM, Tao K, et al: TGF-β1-regulated miR-3691-3p
targets E2F3 and PRDM1 to inhibit prostate cancer progression.
Asian J Androl. 23:188–196. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng J, Xu TT, Chen F and Zhang Y:
miRNA-195-5p functions as a tumor suppressor and a predictive of
poor prognosis in non-small cell lung cancer by directly targeting
CIAPIN1. Pathol Oncol Res. 25:1181–1190. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo JH, Pan JS, Jin Y, Li MY and Chen M:
miR-195-5p inhibits proliferation and induces apoptosis of
non-small cell lung cancer cells by targeting CEP55. Onco Targets
Ther. 12:11465–11474. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Du W, Liu T, Zhang Y, Zeng Y, Zhu J, Tang
H, Liu Z and Huang JA: miR-195-5p is a potential factor responsible
for CPNE1 differential expression between subtypes of non-small
cell lung cancer. J Cancer. 11:2610–2620. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu XM, Zhou Y, Ning YE, Gu H, Tong YX and
Wang N: miR-195-5p inhibits malignant progression of cervical
cancer by targeting YAP1. Onco Targets Ther. 13:931–944. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li M, Ren CX, Zhang JM, Xin XY, Hua T and
Wang HB and Wang HB: The effects of miR-195-5p/MMP14 on
proliferation and invasion of cervical carcinoma cells through TNF
signaling pathway based on bioinformatics analysis of microarray
profiling. Cell Physiol Biochem. 50:1398–1413. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu J, Ji A, Wang X, Zhu Y, Yu Y, Lin Y,
Liu Y, Li S, Liang Z, Xu X, et al: MicroRNA-195-5p, a new regulator
of Fra-1, suppresses the migration and invasion of prostate cancer
cells. J Transl Med. 13:2892015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai C, Chen QB, Han ZD, Zhang YQ, He HC,
Chen JH, Chen YR, Yang SB, Wu YD, Zeng YR, et al: miR-195 inhibits
tumor progression by targeting RPS6KB1 in human prostate cancer.
Clin Cancer Res. 21:4922–4934. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai C, He H, Duan X, Wu W, Mai Z, Zhang T,
Fan J, Deng T, Zhong W, Liu Y, et al: miR-195 inhibits cell
proliferation and angiogenesis in human prostate cancer by
downregulating PRR11 expression. Oncol Rep. 39:1658–1670.
2018.PubMed/NCBI
|
|
25
|
Alexandratou E, Yova D, Gorpas D, Maragos
P, Agrogiannis G and Kavantzas N: Texture analysis of tissues in
Gleason grading of prostate cancer. Int Soc Opt Photon.
6859:6859042008.
|
|
26
|
Ozkan TA, Eruyar AT, Cebeci OO, Memik O,
Ozcan L and Kuskonmaz I: Interobserver variability in Gleason
histological grading of prostate cancer. Scand J Urol. 50:420–424.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li M, Liu B, Yi J, Yang Y, Wang J, Zhu WG
and Luo J: MIB1-mediated degradation of WRN promotes cellular
senescence in response to camptothecin treatment. FASEB J.
34:11488–11497. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koo BK, Lim HS, Song R, Yoon MJ, Yoon KJ,
Moon JS, Kim YW, Kwon MC, Yoo KW, Kong MP, et al: Mind bomb 1 is
essential for generating functional Notch ligands to activate
Notch. Development. 132:3459–3470. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cajánek L, Glatter T and Nigg EA: The E3
ubiquitin ligase Mib1 regulates Plk4 and centriole biogenesis. J
Cell Sci. 128:1674–1682. 2015.PubMed/NCBI
|
|
31
|
Zhang X, Zhou J, Xue D, Li Z, Liu Y and
Dong L: miR-515-5p acts as a tumor suppressor via targeting TRIP13
in prostate cancer. Int J Biol Macromol. 129:227–232. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhan B, Huang L, Chen Y, Ye W, Li J, Chen
J, Yang S and Jiang W: miR-196a-mediated downregulation of p27
protein promotes prostate cancer proliferation and relates to
biochemical recurrence after radical prostatectomy. Prostate.
80:1024–1037. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang Y, Jia B, Zhao X, Wang Y and Ye W:
miR-93-5p may be an important oncogene in prostate cancer by
bioinformatics analysis. J Cell Biochem. 120:10463–10483. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nam RK, Benatar T, Wallis CJD, Kobylecky
E, Amemiya Y, Sherman C and Seth A: MicroRNA-139 is a predictor of
prostate cancer recurrence and inhibits growth and migration of
prostate cancer cells through cell cycle arrest and targeting IGF1R
and AXL. Prostate. 79:1422–1438. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Du Y, Liu XH, Zhu HC, Wang L, Ning JZ and
Xiao CC: miR-543 promotes proliferation and epithelial-mesenchymal
transition in prostate cancer via targeting RKIP. Cell Physiol
Biochem. 41:1135–1146. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu F, Li Q, Wang ZY and Cao XM: Sinomenine
inhibits proliferation, migration, invasion and promotes apoptosis
of prostate cancer cells by regulation of miR-23a. Biomed
Pharmacother. 112:1085922019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang P, Zhang L, Yin S, Xu Y, Tai S, Zhang
LI and Liang C: hsa_circ_0062019 promotes the proliferation,
migration, and invasion of prostate cancer cells via the
miR-195-5p/HMGA2 axis. Acta Biochim Biophys Sin (Shanghai).
12:815–822. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Leng W, Liu Q, Zhang S, Sun D and Guo Y:
lncRNA AFAP1-AS1 modulates the sensitivity of paclitaxel-resistant
prostate cancer cells to paclitaxel via miR-195-5p/FKBP1A axis.
Cancer Biol Ther. 21:1072–1080. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xing ZS, Li SL, Liu ZX, Zhang C, Meng MJ
and Bai ZM: The long non-coding RNA LINC00473 contributes to cell
proliferation via JAK-STAT3 signaling pathway by regulating
miR-195-5p/SEPT2 axis in prostate cancer. Biosci Rep.
40:BSR201918502020. View Article : Google Scholar : PubMed/NCBI
|
